SAPCD2 and non-small cell lung carcinoma: SAPCD2 expression has been associated with various malignancies of the lung, including lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), and non-small cell lung cancer (NSCLC) 32.